Xiao Long Zhang
Directeur/Bestuurslid bij Zensun (Shanghai) Sci & Tech Co., Ltd.
Profiel
Xiao Long Zhang is an Independent Member-Supervisory Board at Zensun (Shanghai) Sci & Tech Co., Ltd.
since 2019.
He completed his undergraduate degree from Guanghua School of Management in 2001.
Actieve functies van Xiao Long Zhang
Bedrijven | Functie | Begin |
---|---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Directeur/Bestuurslid | 22-01-2019 |
Opleiding van Xiao Long Zhang
Guanghua School of Management | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Zensun (Shanghai) Sci & Tech Co., Ltd.
Zensun (Shanghai) Sci & Tech Co., Ltd. Pharmaceuticals: MajorHealth Technology Zensun (Shanghai) Sci & Tech Co., Ltd. engages in the research and development of biopharmaceutical products. It offers recombinant protein, Neucardin, for chronic heart failure treatment. It also develops medicine for functional constipation, Alzheimer’s disease, and recurrent urinary tract infection treatment. The company was founded by Ming Dong Zhou and Xi Fu Liu on April 20, 2000 and is headquartered in Shanghai, China. | Health Technology |